Kevin Schultz

Kevin Schultz, DVM, Ph.D. Immunology, Medicine, Microbiology serves as Chair of our scientific advisory board. Kevin has previously served as a chief scientific officer of Kindred Biosciences, chief scientific officer and head of global R&D at Merial, and executive director of worldwide animal science research and development at Merck. Prior to that, he was a Professor of Pathobiological Sciences at the University of Wisconsin-Madison and managed his own veterinary practice. Dr. Schultz serves as an industry consultant for human and animal health research and development and was appointed as CEO of Pathens, LLC. He is also a Venture Fellow with the George Research Alliance. Dr. Schultz is a graduate of the University of Illinois (Ph.D.), Purdue University (DVM), and completed his postdoc at Harvard Medical School.